Ardent Health Partners (ARDT) Stock Forecast & Price Target

$15.82 +0.02 (+0.13%)

(As of 11/22/2024 ET)

Ardent Health Partners - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 12 Analyst Ratings

Sell
0

Hold
2

Buy
10

Based on 12 Wall Street analysts who have issued ratings for Ardent Health Partners in the last 12 months, the stock has a consensus rating of "Buy." Out of the 12 analysts, 2 have given a hold rating, 8 have given a buy rating, and 2 have given a strong buy rating for ARDT.

Consensus Price Target

$21.82
37.92% Upside

According to the 12 analysts' twelve-month price targets for Ardent Health Partners, the average price target is $21.82. The highest price target for ARDT is $27.00, while the lowest price target for ARDT is $18.00. The average price target represents a forecasted upside of 37.92% from the current price of $15.82.

Get the Latest News and Ratings for ARDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ardent Health Partners and its competitors.

ARDT Analyst Ratings Over Time

Type	Current Forecast 11/24/23 to 11/23/24	1 Month Ago 10/25/23 to 10/24/24	3 Months Ago 8/26/23 to 8/25/24	1 Year Ago 11/24/22 to 11/24/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A
Buy	8 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)	N/A
Hold	2 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$21.82	$21.91	$21.70	N/A
Forecasted Upside	37.92% Upside	22.67% Upside	25.65% Upside	N/A
Consensus Rating	Buy	Buy	Buy	N/A

Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

ARDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ARDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ardent Health Partners Stock vs. The Competition

Type	Ardent Health Partners	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	37.92% Upside	26,878.78% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent ARDT News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/14/2024	Royal Bank of Canada 4 of 5 stars	B. Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$23.00 ➝ $23.00	+28.56%
11/12/2024	Leerink Partners 1 of 5 stars		Boost Target	Outperform ➝ Outperform	$23.00 ➝ $25.00	+44.43%
11/6/2024	Bank of America 4 of 5 stars		Downgrade	Buy ➝ Neutral	$22.00 ➝ $19.00	+5.15%
10/11/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$24.00	+32.45%
9/19/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Fidel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$24.00 ➝ $24.00	+37.14%
8/12/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/12/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Greaves Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$18.00 ➝ $18.00	+15.09%
8/12/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Cassorla Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$21.00	+34.27%
8/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$27.00	+72.63%
8/12/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$18.00	+15.09%
8/12/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00	+27.88%
8/12/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$21.00 ➝ $21.00	+34.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:56 AM ET.

ARDT Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Ardent Health Partners is $21.82, with a high forecast of $27.00 and a low forecast of $18.00.
: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ardent Health Partners in the last twelve months. There are currently 2 hold ratings, 8 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ARDT shares.
: According to analysts, Ardent Health Partners's stock has a predicted upside of 37.92% based on their 12-month stock forecasts.
: Over the previous 90 days, Ardent Health Partners's stock had 1 upgrade and 1 downgrade by analysts.
: Ardent Health Partners has been rated by research analysts at Bank of America, KeyCorp, Leerink Partners, Royal Bank of Canada, and Stephens in the past 90 days.
: Analysts like Ardent Health Partners more than other "medical" companies. The consensus rating for Ardent Health Partners is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ARDT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

This page (NYSE:ARDT) was last updated on 11/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardent Health Partners (ARDT) Stock Forecast & Price Target